NCT00644124View on ClinicalTrials.gov

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Lymphoma, Non-Hodgkin

Interventions

DRUG

aflibercept

in combination with standard treatment R-CHOP

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Paris

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY